Choose smart money in health 4 reasons to raise funds with Angels Santé 1 Access our 150+ expert healthcare investors 2 Connect to our French and European healthcare ecosystem 3 Get active support throughout your business development 2 Connect to our French and European healthcare ecosystem 4 Become an exclusive member of the Angels Santé Family How to be selected ? You are a French healthcare start-up (medtech, biotech, diagnostics, e-health, animal health...). You are raising a seed round of between 400 K€ and 2 M€. You have at least one POC (proof of concept). You are strong founders, with a multidisciplinary and complementary team. Your closing date is at least 6 months away. Depending on your sector Biotech : your PoC is at the regulatory preclinical stage (in vivo PoC completed)Medtech : your prototype is finalized and ideally your first pilot studies have been carried out on a few patients,Digital Health: your solution has been developed and is starting to gain commercial traction.Tick all the boxes ?Let's check your eligibility. Submit your application important to know The Angels Santé fundraising process takes an average of 3 to 6 months from application to closing. Before applying, make sure you can anticipate this timeframe. Our selection process Pre-application Submit your application on our Dealum platform 1 1 day Pre-application eligibility check According to our investment thesis 2 2 weeks Selection committee A one-hour meeting before validation to pitch 3 4 to 6 weeks/1 to 1.5 month Pitch to our investors *210 € participation fee per company 4 8 to 12 weeks/ 2 to 3 months Due Diligence ( HR, IP, finance, contracts, négociation …) 5 4 weeks1 month Closing pitch and investment *4.5% Success fee 6 Discover our Portfolio Companies biotech Hephaistos Pharma , 2023 - Paris Hephaistos-Pharma is developing a new generation of immunostimulant to treat metastatic and hardly accessible tumors biotech Alga Therapeutics , 2023 - Rouen Alga Therpeutics produces cancer-fighting antibodies from micro-algae. biotech Abcely , 2023 - Nantes Abcely develops innovative medical and pharmaceutical technologies for the treatment of mucosal cancers. medtech Bliss TX , 2023 - Laval A new generation of digital solutions for pain management throughout the patient journey. biotech Odimma Therapeutics , 2023 - Strasburg Odimma develops personalized immunotherapy using AI and synthetic DNA technology. biotech Kimialys , 2023 - Paris Kimialys offers an innovative, patented chemical coating that improves the reliability of diagnostic tests. See all our invested companies